I joined the Sapkota lab in May 2025, where my PhD project focuses on targeted degradation of trans-membrane proteins via proximity induction. Such an approach holds promise for modulating key disease-driving pathways, such as those implicated in cancer. Moreover, this strategy has broad therapeutic potential and could be adapted to treat a wide range of other diseases.

Prior to joining the Sapkota Lab, I completed my integrated master’s degree at the University of York. My master’s research investigated the role of Virulence-associated protein A in Rhodococcus equi pathogenesis and its impact on lysosomal function. During my studies, I also undertook a summer internship at the University of Leeds, where I explored the activity of the 55LCC unfoldase complex during DNA replication. After graduating, I was invited to return to Leeds to continue this work as research technician.